Rani Therapeutics Holdings, Inc.
General ticker "RANI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $34.5M (TTM average)
Rani Therapeutics Holdings, Inc. follows the US Stock Market performance with the rate: 22.0%.
Estimated limits based on current volatility of 2.8%: low 1.31$, high 1.39$
Factors to consider:
- Total employees count: 140 (-14.1%) as of 2023
- Top business risk factors: Liquidity and credit risks, Public health crises, Market disruptions, Market competition, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.17$, 3.90$]
- 2025-12-31 to 2026-12-31 estimated range: [1.26$, 4.01$]
Financial Metrics affecting the RANI estimates:
- Positive: with PPE of -1.3 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -88.91 <= 0.01
- Positive: Investing cash flow per share per price, % of 49.62 > -0.63
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term RANI quotes
Long-term RANI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $1.03MM |
| Operating Expenses | $63.45MM | $66.10MM | $54.34MM |
| Operating Income | $-63.45MM | $-66.10MM | $-53.31MM |
| Non-Operating Income | $0.18MM | $-1.78MM | $23.30MM |
| Interest Expense | $1.07MM | $5.08MM | $5.03MM |
| R&D Expense | $36.61MM | $39.62MM | $26.68MM |
| Income(Loss) | $-63.27MM | $-67.88MM | $-30.02MM |
| Taxes | $0.07MM | $0.00MM | $26.57MM |
| Profit(Loss)* | $-30.59MM | $-33.97MM | $-30.02MM |
| Stockholders Equity | $36.85MM | $12.87MM | $1.99MM |
| Assets | $108.03MM | $57.92MM | $36.63MM |
| Operating Cash Flow | $-46.52MM | $-51.24MM | $-35.50MM |
| Capital expenditure | $1.62MM | $1.23MM | $0.27MM |
| Investing Cash Flow | $-72.44MM | $29.86MM | $19.81MM |
| Financing Cash Flow | $29.00MM | $0.23MM | $13.59MM |
| Earnings Per Share** | $-1.28 | $-1.33 | $-1.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.